TAFI: a promising drug target?

Thromb Haemost. 2004 Mar;91(3):420-2.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Blood Coagulation
  • Carboxypeptidase B2 / therapeutic use*
  • Carboxypeptidases / antagonists & inhibitors
  • Fibrinolysis
  • Humans
  • Myocardial Infarction / drug therapy
  • Plant Proteins / metabolism
  • Plasminogen Activators
  • Thrombin / metabolism
  • Thrombosis / drug therapy

Substances

  • Plant Proteins
  • Carboxypeptidases
  • Carboxypeptidase B2
  • Plasminogen Activators
  • Thrombin